Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast Cancer.

Proteomics. Clinical applications - 1 Sept 2018

Jin Min-Sun, Lee Hyebin, Woo Jongmin, Choi Seongmin, Do Mi Sol, Kim Kwangsoo, Song Min Ji, Kim Youngsoo, Park In Ae, Han Dohyun, Ryu Han Suk

Abstract excerpt

PURPOSE: Secretory carcinoma (SC) of the breast is defined as an indolent tumor but is still categorized into a basal-like triple-negative breast cancer (BL-TNBC) subgroup that generally shows aggressive behavior according to the current classification. Despite the unique clinical behavior of SC, molecular characteristics that reflect biological behaviors of SC remain largely unknown. EXPERIMENTAL DESIGN: A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exome Sequencing

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Proteomics

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 29476606
DOI: 10.1002/prca.201700125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast Cancer.PMID 29476606Read ↗

The Molecular Landscape and Utility of Multiomic Analyses in Triple Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

Single Cell Omics of Breast Cancer: An Update on Characterization and DiagnosisSemantic proximity Read ↗

Advancements in Single-Cell Proteomics and Mass Spectrometry-Based Techniques for Unmasking Cellular Diversity in Triple Negative Breast CancerSemantic proximity Read ↗

The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity Read ↗

Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomesSemantic proximity Read ↗

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read ↗

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity Read ↗

Integration of proteomics in the molecular tumor boardSemantic proximity Read ↗

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.Semantic proximity Read ↗

Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypesSemantic proximity Read ↗

Quantitative proteomics analysis of triple-negative breast cancersSemantic proximity Read ↗

Quantitative Proteomics of Breast Benign and Malignant Tumors Reveals a Malignancy SignatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.